Evaluation of Effectiveness of Risperdal® Consta® Compared to Abilify® Over a Two-year Period in Patients With Schizophrenia
Conditions
- Schizophrenia
- Psychotic Disorders
Interventions
- DRUG: Abilify
- DRUG: Risperidal Consta
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators